AbbVie

NYSE
ABBV
Stock
Yield per half year: -10.35%
Dividend yield: 3.25%
Sector: Healthcare

190.28 $

-0.55 $ -0.2882%
164.99 $
216.66 $

Min/max per year

Share chart AbbVie

Main settings

IPO date
2013-01-02
ISIN
US00287Y1091
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
3.36
Дивиденд ао
3.28
Сайт

Grade

Underestimation
Title Value Grade
P/S 5.59 2
P/BV 93.66 1
P/E 73.65 1
Efficiency
Title Value Grade
ROA 3.17 1
ROE 62.52 10
ROIC 15.29 5
Dividends
Title Value Grade
Dividend yield 3.25 8.13
DSI 1 10
Average dividend growth 6.92 10
Debt
Title Value Grade
Debt/EBITDA 4.55 1
Debt/Ratio 0.5019 9
Debt/Equity 20.4 0
Growth impulse
Title Value Grade
Revenue, % 23 4
Ebitda, % 114.53 10
EPS, % -12.58 0

Dividends

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 190.83 $ 0 $ 0 $ -0.2882 % 0 % 0 %
Week 184.85 $ 187.11 $ 190.83 $ +2.94 % 0 % 0 %
Month 189.28 $ 182.31 $ 195 $ +0.5283 % 0 % 0 %
Three month 182.54 $ 177.44 $ 198.47 $ +4.24 % 0 % 0 %
Half a year 212.25 $ 170.16 $ 216.66 $ -10.35 % 0 % 0 %
Year 189.65 $ 164.99 $ 216.66 $ +0.3322 % 0 % 0 %
3 years 144.52 $ 132.51 $ 216.66 $ +31.66 % 0 % 0 %
5 years 111.38 $ 80.26 $ 216.66 $ +70.84 % 0 % 0 %
10 years 63.25 $ 48.27 $ 216.66 $ +200.84 % 0 % 0 %
Year to date 205.02 $ 169.2 $ 216.66 $ -7.19 % 0 % 0 %

Main owners

Contained in ETF

ETF
Share, %
Profitability for 1 year, %
Commission, %
MicroSectors Cannabis 2X Leveraged ETN 9.44 88.65 0.95
iShares Evolved U.S. Innovative Healthcare ETF 5.87 0.000586 0.18
AdvisorShares Vice ETF 4.32 5.43 0.99
2nd Vote Society Defended ETF 4.15 0 0.75
AVDR U.S. LargeCap ESG ETF 4.08 0 0.60
Apex Healthcare ETF 4.02 0 0.95
Vesper U.S. Large Cap Short-Term Reversal Strategy ETF 3.98632 0.0685 0.75
UPHOLDINGS Compound Kings ETF 3.95159 -1.7 0.35
John Hancock Multifactor Healthcare ETF 3.24 29.34 0.40
Donoghue Forlines Innovation ETF 3.21601 20.73 0.69
Global X Longevity Thematic ETF 3.16 -2.24 0.50
iShares Evolved U.S. Healthcare Staples ETF 3.03 31.23 0.18
FCF US Quality ETF 2.88582 9.04 0.59
BNY Mellon Sustainable US Equity ETF 2.53 0 0.50
Franklin U.S. Low Volatility ETF 2.34765 -7.74 0.29
FlexShares Quality Dividend Dynamic Index Fund 1.94 33.57 0.37
Trajan Wealth Income Opportunities ETF 1.93117 -2.63 0.85
ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN 1.39 0 0.30
iShares Factors US Blend Style ETF 1.33 44.21 0.25
iShares Morningstar Large-Cap Value ETF 1.31728 51.43 0.25
US Equity Dividend Select ETF 1.27011 -18.62 0.50
Invesco Defensive Equity ETF 1.08 -6.85 0.55
Tactical Income ETF 0.97 0 1.59
Principal US Large-Cap Adaptive Multi-Factor ETF 0.85 0 0.15
iShares Morningstar Large-Cap ETF 0.68025 186.3 0.03
Fidelity New Millennium ETF 0.64952 -11 0.38
Columbia U.S. ESG Equity Income ETF 0.60155 -4.51 0.35
JPMorgan Corporate Bond Research Enhanced ETF 0.13 -0.2672 0.09
2.6615.870.51

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Richard A. Gonzalez Executive Chairman 7.19M 1954 (71 year)
Mr. Robert A. Michael CEO & Director 4.62M 1970 (55 years)
Ms. Elizabeth Shea Senior Vice President of Investor Relations N/A
Mr. Timothy J. Richmond Executive VP & Chief Human Resources Officer 1.12M 1966 (59 years)
Mr. Jeffrey Ryan Stewart Executive VP & Chief Commercial Officer 4.32M 1969 (56 years)
Dr. Azita Saleki-Gerhardt Ph.D. Executive VP & COO 3.51M 1963 (62 years)
Mr. Scott T. Reents Executive VP & CFO 3.13M 1968 (57 years)
Mr. Sanjay Narayan Senior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic Legal N/A
Mr. Perry C. Siatis Executive VP, General Counsel & Secretary N/A 1975 (50 years)
Dr. Roopal Thakkar M.D. Executive VP of Research and Development & Chief Scientific Officer 1972 (53 years)

About company

Address: United States, North Chicago, 1 North Waukegan Road - Open in google maps, Open in yandex maps
Website: http://www.abbvie.com

About AbbVie

19 октября 2011 года Abbott Laboratories объявила о своем плане разделения на две публично торгуемые компании. » Новые " лаборатории Abbott будут специализироваться на разнообразных продуктах, включая медицинские приборы, диагностическое оборудование и продукты питания, в то время как AbbVie будет работать как фармацевтический производитель, основанный на исследованиях